Jacob Vincent Micallef - 29 Aug 2023 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
Chief Scientific Officer
Signature
/s/ Jacob Vincent Micallef
Issuer symbol
VNRX
Transactions as of
29 Aug 2023
Net transactions value
+$25,062
Form type
4
Filing time
31 Aug 2023, 09:35:31 UTC
Previous filing
28 Aug 2023
Next filing
26 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Purchase $13,950 +11,250 +32% $1.24 46,250 29 Aug 2023 By Spouse
transaction VNRX Common Stock Purchase $11,112 +8,750 +19% $1.27 55,000 30 Aug 2023 By Spouse
holding VNRX Common Stock 235,140 29 Aug 2023 Direct
holding VNRX Common Stock 38,113 29 Aug 2023 By Borlaug Limited F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.